360 One Quant Fund
The scheme seeks to generate long term capital appreciation for investors from a portfolio of equity and equity related securities selected based on quant theme.
Growthvine rating: 5/5 — ranked #13 of 179 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹19.21 (as of 2026-08-21) |
|---|
| AUM | ₹856 Cr |
|---|
| Expense ratio | 1.79% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Pranav Mise |
|---|
| Exit load | 1% for redemption within 365 days |
|---|
Performance & risk
| Sharpe ratio | 0.61 |
|---|
| Standard deviation | 17.85% |
|---|
| Max drawdown | -22.83% |
|---|
| Alpha | 3.45 |
|---|
| Beta | 1.11 |
|---|
Over 5 years, captured 77.8% of NIFTY Alpha 50's upside and 59.2% of its downside.
Market cap allocation
| Large cap | 72.2% |
|---|
| Mid cap | 27.8% |
|---|
| Small cap | 0.0% |
|---|
Concentration
| Top 5 holdings | 17.5% |
|---|
| Top 10 holdings | 33.6% |
|---|
| Total holdings | 36 |
|---|
Top holdings
- Divis Laboratories Ltd. — 3.5%
- TVS Motor Company Ltd. — 3.5%
- Torrent Pharmaceuticals Ltd. — 3.5%
- Bajaj Finance Limited — 3.5%
- Cholamandalam Investment and Finance Company Ltd — 3.4%
- Bajaj Auto Limited — 3.3%
- Aurobindo Pharma Ltd. — 3.2%
- Marico Limited — 3.2%
- Polycab India Limited — 3.2%
- Tech Mahindra Limited — 3.2%
Top sectors
- Finance & Investments — 14.5%
- Automobile — 13.0%
- Pharma & Biotech — 11.8%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | -3.1% | Q4 (Bottom) | #149 of 167 |
| 2025 | 8.4% | Q1 (Top) | #31 of 132 |
| 2024 | 21.7% | Q2 | #33 of 86 |
| 2023 | 44.8% | Q1 (Top) | #9 of 66 |
| 2022 | 3.0% | Q2 | #28 of 55 |